Solvance Pharma
Healthy75/100LargePharmaceutical
About this account
Commercial-stage; expanding rare-disease pipeline into EU and Japan.
Relationship health
75/100 · HealthyHow this account's health has moved over the last 5 weeks.
100 pts0 pts
4w ago2w agothis week
How touches have landed
Every logged touch with Solvance Pharma, by outcome.
In Progress1100%
Company profile
Not analyzed yet — analyze to qualify its type, ownership and revenue from the web, and the offerings that fit show automatically.
Agent briefing
Solvance Pharma is in good shape — healthy, with $610K of open pipeline to grow. It's single-threaded, so widening the relationship would de-risk the deal. Recommended next move: Re-engage Solvance Pharma.
HealthHealthy (75/100).
Pipeline1 open deal worth $610K.
ThreadingSingle-threaded on Prithvi Nair — widen the relationship to de-risk.
MomentumLast touch Jul 5, 2026 • 8:02 PM.
Recommended: Re-engage Solvance Pharma
Key Contacts
Value PropositionsAI generated
Regulatory Submission Services90% match
Position Regulatory Submission Services against Solvance Pharma's near-term regulatory milestones.
Matched from your Freyr knowledge base
Regulatory Intelligence70% match
Single-pane monitoring across FDA, EMA and 120+ agencies.
Matched from your Freyr knowledge base
Angles to researchAI generated
Agent-suggested things worth checking before you reach out — verify before you rely on them.
Regulatory
Check for recent Pharmaceutical guidance that could tighten their submission timelines — a timely reason to reach out.
Hiring
See whether Solvance is hiring in regulatory affairs — a growing team often means more submission workload they may need help with.